Mark Prussian – CEO
Mark M. Prussian is a board-certified healthcare administrator and Chief Executive Officer of The Eye Care Institute. Prussian has served as CEO since 1995 and is responsible for all non-clinical matters at The Eye Care Institute including strategic planning and growth, personnel, training, budgeting, managed care, billing, contracts, purchasing, IT and computers, advertising, real estate, optical, LASIK development and clinical trials. Read Full Bio
Our Facility
Butchertown Clinical Trials is a dedicated clinical research facility on our 21,000 sq. ft. medical campus. It is equipped with the following features and amenities.
- Dedicated, specifically designed, multi-study 4-meter exam lanes featuring ETDRS and electronic visual acuity testing with specialized lighting meet any protocol-specific lighting requirements
- Two medical exam rooms, in addition to a procedure room
- State-of-the-art diagnostic equipment
- Designated monitoring work area with high-speed internet and phone access
Our Client’s Success – 12 Approved Drugs
Just Announced … Our Clients’ Most Recent Success, 13th and 14th Approved Drugs
Who We Are
Butchertown Clinical Trials is an Ophthalmic, Vaccine, Adult Medicine and Metabolic Disease Clinical Trials Research Site in Louisville, KY.
We Are An Experienced Clinical Trials Site
- A freestanding clinical trial building now in design on our 5-acre medical campus. NOW OPEN
- Dedicated office space for monitors with high-speed internet access
- Twelve trial drugs or devices received FDA approval
- Four trial drugs nearing FDA approval status
- Six Principal Investigators
- A national reputation as a superior, compliant, high enrolling ophthalmic trials site
- Experienced site with over 300 trials completed
- Six full-time clinical trials staff members
- Data-rich ophthalmic EMR access to over 78,000 patients with all conditions allowing Butchertown Clinical Trials to recruit for any Adult Medicine, Metabolic, Nutrition, Cancer Genomics, and Vaccine studies.
